Page last updated: 2024-11-02

phenylbutazone and Acute Febrile Neutrophilic Dermatosis

phenylbutazone has been researched along with Acute Febrile Neutrophilic Dermatosis in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
"Phenylbutazone-induced sialadenitis is rare and presents unrecognized adverse effects that may be associated with a systemic reaction."1.35[Sweet's syndrome and phenylbutazone-induced sialadenitis]. ( Girardin, P; Humbert, P; Levang, J; Muller, P, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levang, J1
Muller, P1
Girardin, P1
Humbert, P1

Other Studies

1 other study available for phenylbutazone and Acute Febrile Neutrophilic Dermatosis

ArticleYear
[Sweet's syndrome and phenylbutazone-induced sialadenitis].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Humans; Middle Aged; Phenylbutazone

2008